Sort
15,273 grants matching “antimicrobial resistance”
Use of host derived lipoate by Listeria monocytogenes
$254,401Mary O'Riordan · University Of Michigan At Ann Arbor · R01 · FY2009 · AI
Structural Biology of Gram Positive Virulence Factors
$254,348University Of Minnesota Twin Cities · R01 · FY2004 · AI
INNATE HOST DEFENSE IN THE HUMAN VAGINA
$254,315University Of California Los Angeles · R01 · FY2000 · AI
Screening for Fluoroquinolone-Resistant Viridans Group Streptococci to Individualize Infection Prevention Strategies in Neutropenic Patients
$254,250Michael Joseph Satlin · Weill Medical Coll Of Cornell Univ · R21 · FY2025 · AI
THE ROLE OF UBIQUILINS IN INNATE IMMUNITY TO TUBERCULOSIS
$254,250Jennifer A Philips · New York University School Of Medicine · R21 · FY2014 · AI
Targeted Degradation of Mycobacterial PknG for Host Control of Tuberculosis
$254,250Carl F Nathan · Weill Medical Coll Of Cornell Univ · R21 · FY2025 · AI
âProtection from MRSA lethality by inhibiting LXRα phosphorylationâ
$254,250Michael J Garabedian · New York University School Of Medicine · R21 · FY2023 · AI
Determination of the mode of action of the antibiotic pyrazinamide
$254,250Alexandre Gouzy · Weill Medical Coll Of Cornell Univ · R21 · FY2024 · AI
Investigating the relationship between antibiotics and nosocomial pneumonia.
$254,250Victor J Torres · New York University School Of Medicine · R21 · FY2020 · AI
Discovery of antibiotics active against multidrug resistant bacteria
$254,250Roberto G. Kolter · Harvard Medical School · R21 · FY2015 · AI
Pediatric Infectious Diseases Research Training
$254,189Michael R Wessels · Boston Children'S Hospital · T32 · FY2011 · HD
The Effects of Sex Hormones on Chlamydia Infection
$254,106Isabelle Derre · University Of Maryland Baltimore · U19 · FY2022 · AI
Polymicrobial Context of Neisseria gonorrhoeae Infection and Mucosal Immune Response
$254,106Alison K Criss · University Of Maryland Baltimore · U19 · FY2022 · AI
New Nosocomial Interventions to Decrease Antimicrobial Resistance Transmission
$254,032Anthony D Harris · University Of Maryland Baltimore · R01 · FY2006 · CI
Defining novel mechanisms of clonal emergence in Group A Streptococcus
$254,000Samuel A Shelburne · University Of Tx Md Anderson Can Ctr · R21 · FY2021 · AI
BACTERIA DERIVED SMALL MOLECULES AS NOVEL ANTIMICROBIAL ADJUVANTS FOR THE TREATMENT OF NOSOCOMIAL AND DRUG-RESISTANT BACTERIAL INFECTIONS
$253,942The Research Institute Of The Mcgill University Health Centre · · FY2016 · Department of Defense
Planning for the Metformin for TB/HIV Host-directed Therapy (METHOD) Trial
$253,930Hardy Kornfeld · Univ Of Massachusetts Med Sch Worcester · R34 · FY2016 · AI
The oral mucosal proteome: perturbation in HIV infection and Candida co infection
$253,870Stephen J Challacombe · King'S College London · R01 · FY2010 · DE
Development of CSIC as a Microbicide
$253,742Michael A Parniak · University Of Pittsburgh At Pittsburgh · U19 · FY2010 · AI
The Role of Humectants and Flavor on Microbial Growth in Waterpipe Tobacco
$253,721Anna Marie Adetona · Battelle Centers/Pub Hlth Res & Evaluatn · R21 · FY2019 · CA
SBIR Phase I: Non-pharmaceutical, light and ultrasound combination therapy to prevent SSI's and HAI's
$253,670Vipula Tailor · Sonix Medical Devices Inc. · · FY2020 · TIP
Targetting InhA For Anti-TB Drug Discovery
$253,625State University New York Stony Brook · R01 · FY2005 · AI
The impact of gestational diabetes on Group B Streptococcal virulence and host immune response
$253,614Katy Patras · Baylor College Of Medicine · R21 · FY2023 · AI
Genetic Mechanisms of Gonococcal Resestance to Mediators of Innate Immunity
$253,614William Maurice Shafer · Univ Of North Carolina Chapel Hill · U19 · FY2010 · AI
Effects of Probiotics in Patients with Cystic Fibrosis
$253,500Patricia L Hibberd · Massachusetts General Hospital · U01 · FY2013 · AT